Anti-amoebic drugs in rheumatoid arthritis
Pybus, P.K.
South African Medical Journal 63(2): 31
1983
ISSN/ISBN: 0256-9574 PMID: 6849154 Document Number: 201411
Document emailed within 1 workday
Related Documents
Kovarsky, J. 1985: Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis Texas Medicine 81(9): 35-39Scott, I.C.; Kingsley, G.H.; Scott, D.L. 2013: Can we discontinue synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis? Clinical and Experimental Rheumatology 31(4 Suppl 78: S4-S8
Kurowski, M.; Dunky, A. 1992: Transdermal absorption of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis patients: I. Diclofenac International Journal of Clinical Pharmacology Therapy and Toxicology 30(11): 479
Menard, H.A.; Mathieu, J.P.; de Medicis, R.; Lussier, A. 1979: Slow onset anti-rheumatic drugs in rheumatoid arthritis: could the presence of antinuclear antibody influence the therapeutic results? Journal of Rheumatology 6(2): 156-162
Gibofsky, A.; Cannon, G.W.; Harrison, D.J.; Joseph, G.J.; Bitman, B.; Chaudhari, S.; Collier, D.H. 2015: Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2) Clinical and Experimental Rheumatology 33(3): 297-301
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Chintana, T.; Sucharit, P.; Mahakittikun, V.; Siripanth, C.; Suphadtanaphongs, W. 1986: In vitro studies on the sensitivity of local Entamoeba histolytica to anti-amoebic drugs Southeast Asian Journal of Tropical Medicine and Public Health 17(4): 591-594
Kuru, O.; Bilgici, A.; Birinci, A.; Ulusoy, H.; Durupinar, B. 2009: Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis Bratislavske Lekarske Listy 110(10): 650-654
Sun, J.; Zhang, Y.; Liu, L.; Liu, G. 2014: Diagnostic accuracy of combined tests of anti cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis: a meta-analysis Clinical and Experimental Rheumatology 32(1): 11-21
Goodwin, J.S.; Ceuppens, J.L.; Rodriguez, M.A. 1983: Administration of nonsteroidal anti-inflammatory agents in patients with rheumatoid arthritis. Effects on indexes of cellular immune status and serum rheumatoid factor levels JAMA 250(18): 2485-2488
Yamane, T.; Hashiramoto, A.; Tanaka, Y.; Tsumiyama, K.; Miura, Y.; Shiozawa, K.; Chihara, K.; Shiozawa, S. 2008: Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor Journal of Rheumatology 35(3): 414-420
Sihvonen, S.; Korpela, M.; Mustila, A.; Mustonen, J. 2005: The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis Journal of Rheumatology 32(11): 2089-2094
Sánchez, T.; Contreras-Yáñez, Iú.; Elías-López, D.; Aguilar Salinas, C.A.; Pascual-Ramos, V. 2014: Prevalence of lipid phenotypes, serum lipid behaviour over follow-up and predictors of serum lipid levels in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease-modifying anti-rheumatic drugs Clinical and Experimental Rheumatology 32(4): 509-515
Kim, D.-A.; Jearn, L.-H.; Kim, T.-Y. 2007: Antiperinuclear factor test is more useful than anti-Sa assay when used with anti-cyclic citrullinated peptide test in diagnosis of rheumatoid arthritis Journal of Rheumatology 34(9): 1944-1945
Burmester, G.R.; Emmrich, F. 1993: Anti-CD4 therapy in rheumatoid arthritis Clinical and Experimental Rheumatology 11(Suppl 8): S139-S145
Van der Lubbe, P.A.; Reiter, C.; Riethmüller, G.; Breedveld, F.C. 1993: Anti-CD4 therapy in rheumatoid arthritis Clinical and Experimental Rheumatology 11(Suppl 8): S151
Choy, E.H.; Kingsley, G.H. 1993: Anti-CD4 therapy in rheumatoid arthritis Clinical and Experimental Rheumatology 11(Suppl 8): S147-S149
Breedveld, F.C.; de Vries, R.R. 1992: Anti-CD4 antibodies in rheumatoid arthritis Clinical and Experimental Rheumatology 10(4): 325-326
Sigidin, I.A.; Tsvetkova, E.S.; Bunchuk, N.V. 1981: New drugs in the therapy of rheumatoid arthritis Sovetskaia Meditsina 9: 94-97
Youinou, P.; Brousse, A.; Le Goff, P. 1984: Anti-histone antibodies in rheumatoid arthritis Revue du Rhumatisme et des Maladies Osteo-Articulaires 51(7-8): 419-420